,Set,NGenes,Direction,PValue,FDR
1,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Down,9.32398326663855e-07,0.000766431424517689
2,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Down,1.39987507405752e-05,0.00575348655437641
3,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.000113995587879942,0.0312347910791042
4,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.000205304478044258,0.042190070238095
5,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Down,0.00361709203599505,0.594649930717586
6,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.00564216661808373,0.690267196296738
7,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,5,Up,0.00720431883164098,0.690267196296738
8,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.00782061750813878,0.690267196296738
9,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,12,Down,0.00785367464744652,0.690267196296738
10,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,28,Down,0.0107901534396246,0.690267196296738
11,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,13,Down,0.0108891502692421,0.690267196296738
12,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.0117171730957468,0.690267196296738
13,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,19,Down,0.013427860930705,0.690267196296738
14,WP_FERROPTOSIS,49,Down,0.0147011100918505,0.690267196296738
15,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,71,Down,0.0153580075142507,0.690267196296738
16,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.0160997990217562,0.690267196296738
17,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.0176153281885981,0.690267196296738
18,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.0180914742569418,0.690267196296738
19,WP_PROSTAGLANDIN_SIGNALING,20,Down,0.0185582198493564,0.690267196296738
20,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.0189393322134808,0.690267196296738
21,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Down,0.0195404064133639,0.690267196296738
22,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,31,Down,0.0203494456762606,0.690267196296738
23,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.0212175718962432,0.690267196296738
24,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.0226152535057956,0.690267196296738
25,WP_SPINAL_CORD_INJURY,62,Down,0.022634074530212,0.690267196296738
26,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.0227380280866955,0.690267196296738
27,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.0230205072005303,0.690267196296738
28,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.025159824021708,0.690267196296738
29,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.0258351243403506,0.690267196296738
30,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.0264655040030115,0.690267196296738
31,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.0274134660747487,0.690267196296738
32,WP_PURINE_METABOLISM,10,Up,0.029936000852501,0.690267196296738
33,WP_SILDENAFIL_TREATMENT,12,Up,0.0305007086660266,0.690267196296738
34,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Down,0.0313163258739019,0.690267196296738
35,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,13,Down,0.0319564757365216,0.690267196296738
36,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Down,0.0320219897930709,0.690267196296738
37,WP_VITAMIN_B12_DISORDERS,9,Down,0.0322247406102902,0.690267196296738
38,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,6,Up,0.0329676699617756,0.690267196296738
39,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Up,0.0332384924737705,0.690267196296738
40,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Up,0.034499128690155,0.690267196296738
41,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Down,0.0353255097700433,0.690267196296738
42,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,40,Down,0.0368547028771523,0.690267196296738
43,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,3,Up,0.0368794916345484,0.690267196296738
44,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Up,0.0377210103277117,0.690267196296738
45,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.0379112272212997,0.690267196296738
46,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.0387248720765815,0.690267196296738
47,WP_EBOLA_VIRUS_INFECTION_IN_HOST,106,Down,0.0394678323916626,0.690267196296738
48,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Down,0.0450029541298277,0.740366004595864
49,WP_AGERAGE_PATHWAY,53,Down,0.0452988699848992,0.740366004595864
50,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Down,0.0459330571499966,0.740366004595864
51,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.045935117073466,0.740366004595864
52,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.0474901697131078,0.746192808917022
53,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.0481121884094917,0.746192808917022
54,WP_B_CELL_RECEPTOR_SIGNALING,82,Up,0.0544165481168536,0.788929483702943
55,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,55,Down,0.0557844613201698,0.788929483702943
56,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.05605257983619,0.788929483702943
57,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,34,Down,0.0572047159668043,0.788929483702943
58,WP_16P112_DISTAL_DELETION_SYNDROME,20,Up,0.0577227754510065,0.788929483702943
59,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.0581125857567626,0.788929483702943
60,WP_MELATONIN_METABOLISM_AND_EFFECTS,18,Down,0.0581666626484275,0.788929483702943
61,WP_BENZENE_METABOLISM,3,Down,0.0603500554833941,0.788929483702943
62,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,7,Up,0.0607518223251604,0.788929483702943
63,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,7,Up,0.0607518223251604,0.788929483702943
64,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Up,0.0614728591611039,0.788929483702943
65,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.0628047403641376,0.788929483702943
66,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.0638036949229863,0.788929483702943
67,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.064576669921974,0.788929483702943
68,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.0669509602894818,0.788929483702943
69,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.0671520806641479,0.788929483702943
70,WP_GPCRS_OTHER,11,Up,0.0678635206841961,0.788929483702943
71,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.0694570873625187,0.788929483702943
72,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,66,Down,0.0712281786026997,0.788929483702943
73,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.0713406157476758,0.788929483702943
74,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.0725139273936304,0.788929483702943
75,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Down,0.0725265506176862,0.788929483702943
76,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,46,Down,0.0737318983374177,0.788929483702943
77,WP_DNA_REPLICATION,34,Down,0.07495118473638,0.788929483702943
78,WP_SPINA_BIFIDA,10,Up,0.0756630175390099,0.788929483702943
79,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.0758216900395773,0.788929483702943
80,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,14,Up,0.0780409858022753,0.801871129118378
81,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Down,0.0821230055053071,0.810232905082453
82,WP_ENERGY_METABOLISM,41,Up,0.0829218191012214,0.810232905082453
83,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.0865001861735762,0.810232905082453
84,WP_RETINOL_METABOLISM,6,Down,0.0878482571119561,0.810232905082453
85,WP_MACROPHAGE_MARKERS,8,Up,0.0891200154717338,0.810232905082453
86,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.0900002162702148,0.810232905082453
87,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.0913139128771509,0.810232905082453
88,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.0919930363151555,0.810232905082453
89,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.0928440308303319,0.810232905082453
90,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.0939380242261086,0.810232905082453
91,WP_GPR40_PATHWAY,8,Up,0.0961573871823238,0.810232905082453
92,WP_NOTCH_SIGNALING_WP268,33,Down,0.096331624981801,0.810232905082453
93,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.0964409372428164,0.810232905082453
94,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Down,0.0978964356929481,0.810232905082453
95,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.0996077131005707,0.810232905082453
96,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.100775581462706,0.810232905082453
97,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,15,Up,0.100791631089642,0.810232905082453
98,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.101549879020917,0.810232905082453
99,WP_IRON_METABOLISM_IN_PLACENTA,8,Up,0.102779152876382,0.810232905082453
100,WP_G13_SIGNALING,29,Down,0.104861186338017,0.810232905082453
101,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,45,Down,0.105855820068982,0.810232905082453
102,WP_BLOOD_CLOTTING_CASCADE,5,Up,0.106501291503311,0.810232905082453
103,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.106641754876817,0.810232905082453
104,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.107084984361669,0.810232905082453
105,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.108865323028446,0.810232905082453
106,WP_NRF2_PATHWAY,68,Down,0.109336022407456,0.810232905082453
107,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Up,0.109471633376803,0.810232905082453
108,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.110358018067057,0.810232905082453
109,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Down,0.111501045465311,0.810232905082453
110,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.11154013307934,0.810232905082453
111,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Down,0.113752483063515,0.810232905082453
112,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Down,0.114709213883572,0.810232905082453
113,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.11476578471324,0.810232905082453
114,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,18,Down,0.115232375924037,0.810232905082453
115,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Up,0.11573983171067,0.810232905082453
116,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,14,Up,0.115873542268115,0.810232905082453
117,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Down,0.116222665771763,0.810232905082453
118,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,11,Up,0.116310806325705,0.810232905082453
119,WP_NUCLEAR_RECEPTORS,20,Up,0.117491552010081,0.811580300439382
120,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.118694729181857,0.812863882199955
121,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.120112608739771,0.812863882199955
122,WP_GPCRS_CLASS_B_SECRETINLIKE,3,Up,0.121371751119209,0.812863882199955
123,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.121632916679555,0.812863882199955
124,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,8,Up,0.123343719550146,0.815792615620261
125,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,132,Down,0.125246933378439,0.815792615620261
126,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.125474595756877,0.815792615620261
127,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.127744214928852,0.815792615620261
128,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.128311372557834,0.815792615620261
129,WP_IRON_METABOLISM_DISORDERS,10,Down,0.129439550376885,0.815792615620261
130,WP_INTERFERON_TYPE_I_SIGNALING,50,Up,0.129777997205793,0.815792615620261
131,WP_WNT_SIGNALING_WP363,35,Down,0.130010745311745,0.815792615620261
132,WP_HIPPOYAP_SIGNALING,16,Down,0.132256096319719,0.81653771310123
133,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,73,Down,0.133868521717559,0.81653771310123
134,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,40,Down,0.134012363217967,0.81653771310123
135,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.134319487068268,0.81653771310123
136,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.13692983421324,0.81653771310123
137,WP_MEASLES_VIRUS_INFECTION,99,Down,0.138167408666351,0.81653771310123
138,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,22,Up,0.139408425912578,0.81653771310123
139,WP_LIPID_PARTICLES_COMPOSITION,4,Up,0.139950304580876,0.81653771310123
140,WP_CELL_CYCLE,91,Down,0.140651828685868,0.81653771310123
141,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,32,Down,0.141100379868936,0.81653771310123
142,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.141636740806906,0.81653771310123
143,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.143053386982218,0.81653771310123
144,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.143983711716156,0.81653771310123
145,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Down,0.144036457907151,0.81653771310123
146,WP_PURINERGIC_SIGNALING,14,Down,0.145159918887325,0.817270228256038
147,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,19,Down,0.146500650370223,0.819207718396759
148,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.150993334635453,0.838625142367176
149,WP_ALZHEIMERS_DISEASE,181,Down,0.156512352091095,0.852304378649149
150,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,181,Down,0.156512352091095,0.852304378649149
151,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,3,Up,0.156659024278701,0.852304378649149
152,WP_WNT_SIGNALING_WP428,56,Down,0.157603729385244,0.852304378649149
153,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,8,Down,0.159070488497348,0.854613997024969
154,WP_G1_TO_S_CELL_CYCLE_CONTROL,49,Down,0.16216215519311,0.865566828368417
155,WP_OSTEOBLAST_SIGNALING,3,Down,0.166084392086999,0.872895120661072
156,WP_KIT_RECEPTOR_SIGNALING,49,Up,0.166815750100778,0.872895120661072
157,WP_DOPAMINE_METABOLISM,7,Down,0.167142961402299,0.872895120661072
158,WP_APOPTOSIS_MODULATION_AND_SIGNALING,76,Down,0.168237610705826,0.872895120661072
159,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.170413905845463,0.872895120661072
160,WP_COPPER_HOMEOSTASIS,40,Down,0.178261964148962,0.872895120661072
161,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.178514748538121,0.872895120661072
162,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,9,Down,0.180637043058865,0.872895120661072
163,WP_NRF2ARE_REGULATION,20,Down,0.18090764810618,0.872895120661072
164,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.182078795631043,0.872895120661072
165,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,19,Up,0.18264099644301,0.872895120661072
166,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.183325793649967,0.872895120661072
167,WP_VITAMIN_B12_METABOLISM,23,Down,0.183474909104969,0.872895120661072
168,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,55,Up,0.183488954769107,0.872895120661072
169,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,3,Down,0.184203337242065,0.872895120661072
170,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.184213256539448,0.872895120661072
171,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.184999611090946,0.872895120661072
172,WP_KININKALLIKREIN_PATHWAY,2,Down,0.186221162334049,0.872895120661072
173,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.186746281218626,0.872895120661072
174,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.187057953852245,0.872895120661072
175,WP_RAC1PAK1P38MMP2_PATHWAY,49,Down,0.188493780723545,0.872895120661072
176,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,52,Up,0.189151628447808,0.872895120661072
177,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.189497966529616,0.872895120661072
178,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.190019383536144,0.872895120661072
179,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.190083000727898,0.872895120661072
180,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.195949336037867,0.88753405278584
181,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.199127134938513,0.88753405278584
182,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,52,Down,0.199480971924506,0.88753405278584
183,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.199653590109119,0.88753405278584
184,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Down,0.199675189409394,0.88753405278584
185,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.201035528642767,0.88753405278584
186,WP_HYPERTROPHY_MODEL,13,Down,0.201520624239638,0.88753405278584
187,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.20265265409343,0.88753405278584
188,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.202988323508197,0.88753405278584
189,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.204682135488256,0.890204843234639
190,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,45,Down,0.207066831431616,0.893118259784641
191,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Down,0.208366865783459,0.893118259784641
192,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,12,Down,0.208906719453147,0.893118259784641
193,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.210535196697435,0.893118259784641
194,WP_ONECARBON_METABOLISM,22,Up,0.21323517240868,0.893118259784641
195,WP_NUCLEAR_RECEPTORS_METAPATHWAY,172,Down,0.213311598334144,0.893118259784641
196,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.213718947600767,0.893118259784641
197,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.214678658673845,0.893118259784641
198,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Up,0.217041332535495,0.893118259784641
199,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.217580553325692,0.893118259784641
200,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.219355946517207,0.893118259784641
201,WP_MRNA_PROCESSING,124,Up,0.220542440280656,0.893118259784641
202,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.220570024660827,0.893118259784641
203,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Down,0.221882144045662,0.893118259784641
204,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.222160553634846,0.893118259784641
205,WP_SMALL_LIGAND_GPCRS,7,Down,0.222736305664053,0.893118259784641
206,WP_TRYPTOPHAN_METABOLISM,17,Down,0.22533109255739,0.899136689719293
207,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.227374688501447,0.900734156221191
208,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Up,0.228254456465295,0.900734156221191
209,WP_RETT_SYNDROME,29,Up,0.22911808390039,0.900734156221191
210,WP_NEUROINFLAMMATION,10,Down,0.231339904149348,0.900734156221191
211,WP_MESODERMAL_COMMITMENT_PATHWAY,72,Up,0.232081394056141,0.900734156221191
212,WP_CCL18_SIGNALING,19,Down,0.237401789073146,0.900734156221191
213,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.237554572818559,0.900734156221191
214,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,60,Down,0.23878898454605,0.900734156221191
215,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.240546781120879,0.900734156221191
216,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.242123530060887,0.900734156221191
217,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,50,Down,0.24220188897017,0.900734156221191
218,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.243537700500573,0.900734156221191
219,WP_PDGF_PATHWAY,36,Down,0.244304830343563,0.900734156221191
220,WP_MEVALONATE_PATHWAY,7,Down,0.24565540046523,0.900734156221191
221,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Down,0.248427641195714,0.900734156221191
222,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,17,Up,0.250609942246012,0.900734156221191
223,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.251027302853398,0.900734156221191
224,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Down,0.251655663946215,0.900734156221191
225,WP_GASTRIN_SIGNALING,90,Down,0.251769425483575,0.900734156221191
226,WP_NEURAL_CREST_DIFFERENTIATION,34,Down,0.251913606890013,0.900734156221191
227,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.252620302855669,0.900734156221191
228,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,22,Down,0.253353682463181,0.900734156221191
229,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.253701528634817,0.900734156221191
230,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.254275645257242,0.900734156221191
231,WP_SYNAPTIC_VESICLE_PATHWAY,21,Down,0.254369352826004,0.900734156221191
232,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.255115408736546,0.900734156221191
233,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.255317589293841,0.900734156221191
234,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Down,0.259070219952575,0.905665295908431
235,WP_DRAVET_SYNDROME,11,Down,0.259218696267568,0.905665295908431
236,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.260020693229184,0.905665295908431
237,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.261936393272442,0.908297566006419
238,WP_CILIARY_LANDSCAPE,182,Down,0.264125884002962,0.908297566006419
239,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.265192852823697,0.908297566006419
240,WP_MATRIX_METALLOPROTEINASES,7,Down,0.265196369636911,0.908297566006419
241,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.267100231491488,0.908446029398729
242,WP_JOUBERT_SYNDROME,70,Down,0.267450047584541,0.908446029398729
243,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,10,Up,0.270113591976385,0.910340911926838
244,WP_IL19_SIGNALING,20,Down,0.270222849769037,0.910340911926838
245,WP_AUTOPHAGY,27,Up,0.277052521628579,0.917963478885789
246,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.277720449612868,0.917963478885789
247,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Up,0.278437805990177,0.917963478885789
248,WP_LUNG_FIBROSIS,31,Down,0.280256909599986,0.917963478885789
249,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Down,0.281521065788274,0.917963478885789
250,WP_OREXIN_RECEPTOR_PATHWAY,113,Up,0.282799363258454,0.917963478885789
251,WP_VEGFAVEGFR2_SIGNALING,331,Down,0.284672533469147,0.917963478885789
252,WP_PROTEASOME_DEGRADATION,57,Down,0.284988526182935,0.917963478885789
253,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,71,Down,0.286989211553741,0.917963478885789
254,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.287077530333661,0.917963478885789
255,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.289252016871939,0.917963478885789
256,WP_KLEEFSTRA_SYNDROME,25,Up,0.290305285258317,0.917963478885789
257,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Down,0.291680199800299,0.917963478885789
258,WP_AEROBIC_GLYCOLYSIS,9,Down,0.293079326939167,0.917963478885789
259,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,9,Down,0.293079326939167,0.917963478885789
260,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Up,0.29372893212818,0.917963478885789
261,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,16,Down,0.293954921763445,0.917963478885789
262,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,28,Down,0.294044323927514,0.917963478885789
263,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.294189210123423,0.917963478885789
264,WP_ACUTE_MYELOID_LEUKEMIA,53,Up,0.297794133745547,0.917963478885789
265,WP_IL4_SIGNALING,50,Up,0.299248301987584,0.917963478885789
266,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.300165264181482,0.917963478885789
267,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.302810127156319,0.917963478885789
268,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.302930091373051,0.917963478885789
269,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.304717162449369,0.917963478885789
270,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,29,Up,0.304837100169982,0.917963478885789
271,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Up,0.305426109307538,0.917963478885789
272,WP_NRXN1_DELETION_SYNDROME,2,Up,0.307638657602291,0.917963478885789
273,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.308006016710264,0.917963478885789
274,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Down,0.309676590718148,0.917963478885789
275,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.310514642994829,0.917963478885789
276,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,25,Down,0.311043709456687,0.917963478885789
277,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,6,Down,0.311311781801657,0.917963478885789
278,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.311760384320322,0.917963478885789
279,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Down,0.312866029031804,0.917963478885789
280,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.317571784148341,0.917963478885789
281,WP_PRION_DISEASE_PATHWAY,27,Down,0.32071096030852,0.917963478885789
282,WP_PDGFRBETA_PATHWAY,26,Down,0.321887612658412,0.917963478885789
283,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Down,0.323412721315758,0.917963478885789
284,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.323572720415785,0.917963478885789
285,WP_HISTONE_MODIFICATIONS,35,Up,0.326341535732015,0.917963478885789
286,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Up,0.327349215051508,0.917963478885789
287,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Down,0.328750745942376,0.917963478885789
288,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.331810711348657,0.917963478885789
289,WP_G_PROTEIN_SIGNALING,59,Down,0.33229710921131,0.917963478885789
290,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Down,0.335765570156036,0.917963478885789
291,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,4,Up,0.335859840964762,0.917963478885789
292,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.339195690231122,0.917963478885789
293,WP_BREAST_CANCER_PATHWAY,81,Down,0.339363283729773,0.917963478885789
294,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,12,Down,0.340007192174073,0.917963478885789
295,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.340286098122622,0.917963478885789
296,WP_IL26_SIGNALING,31,Down,0.34042411888945,0.917963478885789
297,WP_NEPHROGENESIS,4,Up,0.340490964533088,0.917963478885789
298,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,14,Up,0.340977583646584,0.917963478885789
299,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,32,Up,0.341413876780722,0.917963478885789
300,WP_ATM_SIGNALING,33,Up,0.341745805230211,0.917963478885789
301,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.342490214851517,0.917963478885789
302,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.343571148194872,0.917963478885789
303,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,10,Up,0.34384753697076,0.917963478885789
304,WP_CREATINE_PATHWAY,2,Up,0.34556873023974,0.917963478885789
305,WP_AMINO_ACID_METABOLISM,57,Down,0.350229136403996,0.917963478885789
306,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.351715219336179,0.917963478885789
307,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.353687092952788,0.917963478885789
308,WP_COMPLEMENT_ACTIVATION,12,Down,0.353836696560915,0.917963478885789
309,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Down,0.3546826748523,0.917963478885789
310,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.355655462644719,0.917963478885789
311,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.357490546499029,0.917963478885789
312,WP_THERMOGENESIS,72,Up,0.357744115722834,0.917963478885789
313,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,75,Down,0.358289212461187,0.917963478885789
314,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,40,Up,0.358373044411499,0.917963478885789
315,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Up,0.358397665418863,0.917963478885789
316,WP_STEROID_BIOSYNTHESIS,2,Up,0.359929655780645,0.917963478885789
317,WP_OPIOID_RECEPTOR_PATHWAYS,24,Down,0.360472024620079,0.917963478885789
318,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.361317090102655,0.917963478885789
319,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.361327775295827,0.917963478885789
320,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Down,0.362824122197118,0.917963478885789
321,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,12,Up,0.36654538948978,0.917963478885789
322,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.366949965746276,0.917963478885789
323,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.367747701646895,0.917963478885789
324,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Up,0.370691697939492,0.917963478885789
325,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,6,Up,0.371491388601298,0.917963478885789
326,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,9,Down,0.372711962195518,0.917963478885789
327,WP_ANDROGEN_RECEPTOR_SIGNALING,76,Down,0.374596987362765,0.917963478885789
328,WP_PEPTIDE_GPCRS,11,Down,0.37581723401211,0.917963478885789
329,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.37760120124964,0.917963478885789
330,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,17,Up,0.378018075983988,0.917963478885789
331,WP_VALPROIC_ACID_PATHWAY,9,Up,0.378398989217415,0.917963478885789
332,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.379393296381729,0.917963478885789
333,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.38075936845666,0.917963478885789
334,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.380798895953085,0.917963478885789
335,WP_BLADDER_CANCER,27,Up,0.380894174703917,0.917963478885789
336,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,26,Down,0.381260798733039,0.917963478885789
337,WP_CHOLESTEROL_METABOLISM,48,Down,0.382470037943104,0.917963478885789
338,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Down,0.383180974860132,0.917963478885789
339,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,40,Down,0.383403397337244,0.917963478885789
340,WP_VITAMIN_D_RECEPTOR_PATHWAY,79,Down,0.384796024069523,0.917963478885789
341,WP_MIRNA_BIOGENESIS,6,Down,0.384992611196276,0.917963478885789
342,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.38542704104691,0.917963478885789
343,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,87,Down,0.386783885726557,0.917963478885789
344,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Down,0.389398627588027,0.917963478885789
345,WP_METABOLIC_EPILEPTIC_DISORDERS,55,Down,0.38950924794258,0.917963478885789
346,WP_HEPATITIS_B_INFECTION,114,Down,0.390618410457705,0.917963478885789
347,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.390880795509382,0.917963478885789
348,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,50,Up,0.391236279468946,0.917963478885789
349,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.392728767587359,0.917963478885789
350,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.395467677917705,0.917963478885789
351,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.399007368291245,0.917963478885789
352,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.399223474256242,0.917963478885789
353,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Up,0.399518171643787,0.917963478885789
354,WP_FOCAL_ADHESION,115,Down,0.400355108050869,0.917963478885789
355,WP_DOPAMINERGIC_NEUROGENESIS,5,Up,0.400903849083933,0.917963478885789
356,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,18,Down,0.401959175175287,0.917963478885789
357,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Down,0.402663221625343,0.917963478885789
358,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.404395291219176,0.917963478885789
359,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.408020146914508,0.917963478885789
360,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.408020146914508,0.917963478885789
361,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.408133285251278,0.917963478885789
362,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.409557252019804,0.917963478885789
363,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.409770593691144,0.917963478885789
364,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,11,Down,0.411498261932772,0.917963478885789
365,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.413990982310509,0.917963478885789
366,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.414835491392637,0.917963478885789
367,WP_ESTROGEN_SIGNALING,21,Down,0.416173353967513,0.917963478885789
368,WP_TP53_NETWORK,15,Up,0.417914748958782,0.917963478885789
369,WP_TARGET_OF_RAPAMYCIN_SIGNALING,31,Down,0.419266918270265,0.917963478885789
370,WP_CIRCADIAN_RHYTHM_GENES,114,Down,0.420569468480585,0.917963478885789
371,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.421032349942845,0.917963478885789
372,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Up,0.421216453895919,0.917963478885789
373,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.421241068006252,0.917963478885789
374,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.422292785743593,0.917963478885789
375,WP_ENDOTHELIN_PATHWAYS,10,Down,0.423851953256233,0.917963478885789
376,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Down,0.424244562921186,0.917963478885789
377,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,24,Up,0.424904229341404,0.917963478885789
378,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.426587849790375,0.917963478885789
379,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Up,0.428266624584316,0.917963478885789
380,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Down,0.429350118033593,0.917963478885789
381,WP_MONOAMINE_TRANSPORT,11,Down,0.429401139408287,0.917963478885789
382,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.430522054884406,0.917963478885789
383,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.432070179207841,0.917963478885789
384,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,87,Up,0.434072644186902,0.917963478885789
385,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.435185040843729,0.917963478885789
386,WP_ID_SIGNALING,11,Up,0.436572737163102,0.917963478885789
387,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.437811306946255,0.917963478885789
388,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,167,Up,0.439168355299578,0.917963478885789
389,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.439409128999136,0.917963478885789
390,WP_TCA_CYCLE_IN_SENESCENCE,9,Down,0.440993721268631,0.917963478885789
391,WP_CHOLESTASIS,8,Up,0.441180463849592,0.917963478885789
392,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.441456402622828,0.917963478885789
393,WP_TGFBETA_RECEPTOR_SIGNALING,34,Up,0.444540645129917,0.917963478885789
394,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.450074309701972,0.917963478885789
395,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.450411376028098,0.917963478885789
396,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Up,0.451743687917505,0.917963478885789
397,WP_RAS_SIGNALING,113,Down,0.451870120743669,0.917963478885789
398,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.452404532154177,0.917963478885789
399,WP_INTEGRINMEDIATED_CELL_ADHESION,70,Down,0.454604109611863,0.917963478885789
400,WP_CORI_CYCLE,11,Down,0.455131508063081,0.917963478885789
401,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.45606450654983,0.917963478885789
402,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.456117248970652,0.917963478885789
403,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,3,Down,0.456431601661018,0.917963478885789
404,WP_TRANSLATION_FACTORS,49,Up,0.457441933814664,0.917963478885789
405,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.459750963795367,0.917963478885789
406,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.460183812853604,0.917963478885789
407,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,62,Down,0.461445078038581,0.917963478885789
408,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.462189290267941,0.917963478885789
409,WP_UROTENSINIIMEDIATED_SIGNALING,48,Down,0.462300529970181,0.917963478885789
410,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Down,0.463193709477211,0.917963478885789
411,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.463495228270224,0.917963478885789
412,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.465130681652039,0.917963478885789
413,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.465616335528152,0.917963478885789
414,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.467933416599007,0.917963478885789
415,WP_PTF1A_RELATED_REGULATORY_PATHWAY,5,Down,0.468477184995908,0.917963478885789
416,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,40,Up,0.468984944544338,0.917963478885789
417,WP_MTHFR_DEFICIENCY,18,Up,0.470822846584358,0.917963478885789
418,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Down,0.473742156464759,0.917963478885789
419,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.474383732453948,0.917963478885789
420,WP_ERBB_SIGNALING,65,Up,0.474868690710522,0.917963478885789
421,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Down,0.475804153830249,0.917963478885789
422,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.475938780795277,0.917963478885789
423,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Down,0.476521346850786,0.917963478885789
424,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.478329893816198,0.917963478885789
425,WP_MELANOMA,53,Down,0.479522642242565,0.917963478885789
426,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.481806844730072,0.917963478885789
427,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.483939563506057,0.917963478885789
428,WP_KREBS_CYCLE_DISORDERS,11,Down,0.48993244651517,0.917963478885789
429,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Down,0.490362918312415,0.917963478885789
430,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.491212442260559,0.917963478885789
431,WP_ESTROGEN_METABOLISM_WP697,5,Down,0.492931057779265,0.917963478885789
432,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Up,0.49428157286085,0.917963478885789
433,WP_TNFALPHA_SIGNALING,83,Down,0.494329726548141,0.917963478885789
434,WP_FOXP3_IN_COVID19,9,Up,0.495301761816811,0.917963478885789
435,WP_FRAGILE_X_SYNDROME,83,Down,0.495471021526948,0.917963478885789
436,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,19,Up,0.496224082250065,0.917963478885789
437,WP_CANCER_PATHWAYS,291,Down,0.496860465647774,0.917963478885789
438,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.498359010046885,0.917963478885789
439,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,2,Down,0.498436726867337,0.917963478885789
440,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Down,0.501819030359208,0.917963478885789
441,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.502444883083812,0.917963478885789
442,WP_IL5_SIGNALING,36,Down,0.503422168057964,0.917963478885789
443,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Down,0.503692354736146,0.917963478885789
444,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.503783836394636,0.917963478885789
445,WP_NOTCH_SIGNALING_WP61,46,Down,0.504222656068505,0.917963478885789
446,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Down,0.507211972368806,0.917963478885789
447,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.50801421013376,0.917963478885789
448,WP_DNA_MISMATCH_REPAIR,21,Up,0.508336243891351,0.917963478885789
449,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,28,Up,0.510698450129035,0.917963478885789
450,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,62,Down,0.512439620351285,0.917963478885789
451,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.512603867942815,0.917963478885789
452,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,3,Down,0.513697376825727,0.917963478885789
453,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,36,Up,0.516084602617502,0.917963478885789
454,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,47,Down,0.51634764533301,0.917963478885789
455,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,16,Up,0.517765455302734,0.917963478885789
456,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.517971083412258,0.917963478885789
457,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.518218159104838,0.917963478885789
458,WP_ONCOSTATIN_M_SIGNALING,52,Up,0.518848112053627,0.917963478885789
459,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,63,Up,0.521271306229168,0.917963478885789
460,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Up,0.52142145629354,0.917963478885789
461,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.521587785709204,0.917963478885789
462,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,20,Down,0.523711557246704,0.917963478885789
463,WP_TROP2_REGULATORY_SIGNALING,41,Down,0.52371189927092,0.917963478885789
464,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Up,0.523908045137531,0.917963478885789
465,WP_ULCERATIVE_COLITIS_SIGNALING,12,Up,0.527152812295115,0.917963478885789
466,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.529133570509778,0.917963478885789
467,WP_HEME_BIOSYNTHESIS,8,Up,0.529133570509778,0.917963478885789
468,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Up,0.529545771489031,0.917963478885789
469,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,6,Down,0.530372823030707,0.917963478885789
470,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.530540020105969,0.917963478885789
471,WP_NPHP1_DELETION_SYNDROME,10,Down,0.533770128636209,0.917963478885789
472,WP_TAR_SYNDROME,43,Down,0.534228355268971,0.917963478885789
473,WP_OSTEOCLAST_SIGNALING,9,Down,0.535263329930054,0.917963478885789
474,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Up,0.537060663224182,0.917963478885789
475,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,80,Down,0.537332995391093,0.917963478885789
476,WP_SLEEP_REGULATION,10,Up,0.538655534582708,0.917963478885789
477,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Down,0.538988904616563,0.917963478885789
478,WP_BENZOAPYRENE_METABOLISM,5,Down,0.541205471410894,0.917963478885789
479,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Up,0.541440320710349,0.917963478885789
480,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.5422280475634,0.917963478885789
481,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.542277425147445,0.917963478885789
482,WP_IL9_SIGNALING,15,Up,0.542711281752474,0.917963478885789
483,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Up,0.545058887330264,0.917963478885789
484,WP_METHYLATION_PATHWAYS,5,Down,0.545307825178491,0.917963478885789
485,WP_IL17_SIGNALING,25,Up,0.547054514980009,0.917963478885789
486,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Down,0.548084493870154,0.917963478885789
487,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Up,0.54922247242671,0.917963478885789
488,WP_LUNG_PATHOLOGY_OF_COVID19,14,Down,0.55160076386669,0.917963478885789
489,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.552165540142697,0.917963478885789
490,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.553950108503649,0.917963478885789
491,WP_RANKLRANK_SIGNALING,47,Up,0.554328383249724,0.917963478885789
492,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.554734884113276,0.917963478885789
493,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.556916217997606,0.917963478885789
494,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,10,Up,0.556920753876046,0.917963478885789
495,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Up,0.556928321439353,0.917963478885789
496,WP_BASE_EXCISION_REPAIR,29,Up,0.560200059789693,0.917963478885789
497,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.561260992368511,0.917963478885789
498,WP_MICROTUBULE_CYTOSKELETON_REGULATION,34,Down,0.563697041721415,0.917963478885789
499,WP_PLEURAL_MESOTHELIOMA,240,Down,0.564307091235221,0.917963478885789
500,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.564370945421789,0.917963478885789
501,WP_HIPPO_SIGNALING_REGULATION,42,Down,0.564601648609976,0.917963478885789
502,WP_NEPHROTIC_SYNDROME,28,Down,0.565438244713476,0.917963478885789
503,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.565744990541155,0.917963478885789
504,WP_EICOSANOID_SYNTHESIS,13,Up,0.566122893849404,0.917963478885789
505,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,6,Down,0.566415742817866,0.917963478885789
506,WP_AXON_GUIDANCE,35,Down,0.566965997697416,0.917963478885789
507,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,35,Down,0.567052893565327,0.917963478885789
508,WP_ARYLAMINE_METABOLISM,1,Down,0.567305896926984,0.917963478885789
509,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.570665380229551,0.920182829479378
510,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Down,0.571604860864519,0.920182829479378
511,WP_GLUTATHIONE_METABOLISM,10,Down,0.572035797888032,0.920182829479378
512,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.575725815555073,0.921311684503159
513,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.576517474981558,0.921311684503159
514,WP_NEOVASCULARIZATION_PROCESSES,21,Down,0.580841938323665,0.921311684503159
515,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Down,0.580921772782074,0.921311684503159
516,WP_WHITE_FAT_CELL_DIFFERENTIATION,22,Up,0.581500157420778,0.921311684503159
517,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.581805581980874,0.921311684503159
518,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,34,Up,0.582002183035238,0.921311684503159
519,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.582638811964534,0.921311684503159
520,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.583143838314451,0.921311684503159
521,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.58440579172683,0.921311684503159
522,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,34,Down,0.585066544173539,0.921311684503159
523,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.588227563020929,0.923798712720188
524,WP_TRANSSULFURATION_PATHWAY,8,Up,0.588893583291215,0.923798712720188
525,WP_DISORDERS_IN_KETOLYSIS,3,Down,0.591922931788905,0.926782190343771
526,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Down,0.594077687244413,0.927046326773024
527,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.594347219232827,0.927046326773024
528,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.599650484725864,0.93272045226798
529,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Down,0.601643994066836,0.93272045226798
530,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,25,Down,0.602796344974373,0.93272045226798
531,WP_MAPK_SIGNALING,158,Down,0.604812112991278,0.93272045226798
532,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.605367001875958,0.93272045226798
533,WP_HUNGER_AND_SATIETY,2,Up,0.607979505284113,0.93272045226798
534,WP_FATTY_ACID_BETAOXIDATION,28,Down,0.609561752623086,0.93272045226798
535,WP_MONOAMINE_GPCRS,3,Down,0.609619390452931,0.93272045226798
536,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Up,0.610080808206223,0.93272045226798
537,WP_OSTEOPONTIN_SIGNALING,11,Up,0.610211829155779,0.93272045226798
538,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.610466670705807,0.93272045226798
539,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.61177080861512,0.932978858407475
540,WP_BARDETBIEDL_SYNDROME,64,Up,0.617432699880459,0.93871081550153
541,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Down,0.618034790519681,0.93871081550153
542,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.618955306571569,0.93871081550153
543,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Down,0.622279099843583,0.939513926488687
544,WP_ALPHA_6_BETA_4_SIGNALING,26,Up,0.622884814220767,0.939513926488687
545,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Up,0.623378976504136,0.939513926488687
546,WP_IRINOTECAN_PATHWAY,5,Down,0.625754870789123,0.939513926488687
547,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.627383666836459,0.939513926488687
548,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.628025659777402,0.939513926488687
549,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.628488709049202,0.939513926488687
550,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.631083595463898,0.939513926488687
551,WP_IDO_METABOLIC_PATHWAY,6,Up,0.63123560735368,0.939513926488687
552,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.632105908005796,0.939513926488687
553,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Up,0.634451276450618,0.939513926488687
554,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.634731439144048,0.939513926488687
555,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,8,Down,0.636358305110982,0.939513926488687
556,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Down,0.636469560781838,0.939513926488687
557,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,72,Down,0.63741706811331,0.939513926488687
558,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,43,Down,0.637827729240778,0.939513926488687
559,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,38,Up,0.639351854737467,0.939513926488687
560,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Up,0.640058149432682,0.939513926488687
561,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,78,Down,0.642549482848672,0.941489616580407
562,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,20,Down,0.645239123766461,0.943748326932439
563,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Up,0.646577931310738,0.944026748734327
564,WP_PREIMPLANTATION_EMBRYO,21,Up,0.650466350552874,0.946343438817799
565,WP_COMPLEMENT_SYSTEM,50,Down,0.65046720551345,0.946343438817799
566,WP_ALSTROM_SYNDROME,27,Up,0.652255015372452,0.947267884516176
567,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.653720130443642,0.947274184172523
568,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Up,0.655147462622157,0.947274184172523
569,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.657286568889592,0.947274184172523
570,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Up,0.659497024871596,0.947274184172523
571,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.659809848956315,0.947274184172523
572,WP_TYPE_II_DIABETES_MELLITUS,14,Up,0.662477708134136,0.947274184172523
573,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.664215225790184,0.947274184172523
574,WP_NAD_METABOLISM,12,Up,0.664666873177164,0.947274184172523
575,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Up,0.665017606115851,0.947274184172523
576,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.665775057899726,0.947274184172523
577,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,48,Up,0.668458136267913,0.947274184172523
578,WP_IL18_SIGNALING,184,Down,0.670585225004277,0.947274184172523
579,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,13,Up,0.670710433478029,0.947274184172523
580,WP_RETINOBLASTOMA_GENE_IN_CANCER,64,Down,0.671666775581201,0.947274184172523
581,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.673312978137082,0.947274184172523
582,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.67371486644764,0.947274184172523
583,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.674889353057334,0.947274184172523
584,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.674969951581651,0.947274184172523
585,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.675519989200323,0.947274184172523
586,WP_SERINE_METABOLISM,5,Up,0.675527238962958,0.947274184172523
587,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.676459788454101,0.947274184172523
588,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.679981291239614,0.949253830652919
589,WP_GALANIN_RECEPTOR_PATHWAY,11,Up,0.681454691771641,0.949253830652919
590,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.68207326623552,0.949253830652919
591,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.682791945649647,0.949253830652919
592,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,79,Up,0.684359672498482,0.949253830652919
593,WP_IL1_SIGNALING,52,Down,0.685600781377477,0.949253830652919
594,WP_INTEGRATED_CANCER_PATHWAY,38,Up,0.688353317449121,0.949253830652919
595,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.689480215602008,0.949253830652919
596,WP_TAMOXIFEN_METABOLISM,2,Down,0.690598427503404,0.949253830652919
597,WP_SMALL_CELL_LUNG_CANCER,67,Down,0.691556994783687,0.949253830652919
598,WP_KALLMANN_SYNDROME,10,Down,0.692738727537312,0.949253830652919
599,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Up,0.693045055800222,0.949253830652919
600,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.696125964497841,0.949253830652919
601,WP_CYTOSINE_METHYLATION,7,Up,0.696552372813759,0.949253830652919
602,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.697176973340366,0.949253830652919
603,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.699903003934548,0.949253830652919
604,WP_ENDOCHONDRAL_OSSIFICATION,26,Up,0.700950998224525,0.949253830652919
605,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Up,0.700950998224525,0.949253830652919
606,WP_DNA_DAMAGE_RESPONSE,56,Down,0.702218827734731,0.949253830652919
607,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,58,Down,0.703670647517497,0.949253830652919
608,WP_PPAR_SIGNALING,36,Down,0.704009018729344,0.949253830652919
609,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Up,0.705555592264261,0.949253830652919
610,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,43,Down,0.705952472288229,0.949253830652919
611,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,31,Down,0.707006682277813,0.949253830652919
612,WP_P38_MAPK_SIGNALING,30,Up,0.707383041703058,0.949253830652919
613,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.70789853794433,0.949253830652919
614,WP_NONSMALL_CELL_LUNG_CANCER,57,Up,0.712663670216898,0.954087193677997
615,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Down,0.716493883450692,0.957655239343852
616,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,31,Up,0.723713396923646,0.96358711522291
617,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Down,0.724800080711356,0.96358711522291
618,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,37,Up,0.724827309210624,0.96358711522291
619,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,57,Down,0.726655219577103,0.96358711522291
620,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.726793201263022,0.96358711522291
621,WP_EGFEGFR_SIGNALING,136,Down,0.730452945591964,0.965813908634215
622,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Up,0.730822689988421,0.965813908634215
623,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.734295713909773,0.96741669345324
624,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Up,0.734507342285686,0.96741669345324
625,WP_SEROTONIN_AND_ANXIETY,5,Up,0.739136165298804,0.96741669345324
626,WP_FOLATE_METABOLISM,36,Down,0.74002086551167,0.96741669345324
627,WP_TGFB_SMAD_SIGNALING,7,Down,0.74031431845119,0.96741669345324
628,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Down,0.740766311481008,0.96741669345324
629,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.742363228570321,0.96741669345324
630,WP_WNT_SIGNALING_AND_PLURIPOTENCY,55,Down,0.742435059582302,0.96741669345324
631,WP_ENDOMETRIAL_CANCER,47,Up,0.743806055672565,0.96741669345324
632,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,7,Down,0.743839301288214,0.96741669345324
633,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.746353136609875,0.96741669345324
634,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,16,Down,0.747256745239725,0.96741669345324
635,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.74939425964505,0.96741669345324
636,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.751795640896543,0.96741669345324
637,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.752248816965347,0.96741669345324
638,WP_METASTATIC_BRAIN_TUMOR,5,Down,0.752617038873114,0.96741669345324
639,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Down,0.752882557804814,0.96741669345324
640,WP_GASTRIC_CANCER_NETWORK_2,23,Up,0.754249736929259,0.96741669345324
641,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,81,Up,0.75439671594103,0.96741669345324
642,WP_PROLACTIN_SIGNALING,68,Up,0.76160790182239,0.974918347544294
643,WP_CHEMOKINE_SIGNALING,106,Up,0.764994919800839,0.974918347544294
644,WP_5Q35_COPY_NUMBER_VARIATION,74,Up,0.765701707846932,0.974918347544294
645,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.768334684919982,0.974918347544294
646,WP_ZINC_HOMEOSTASIS,23,Up,0.768410560627969,0.974918347544294
647,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,50,Down,0.768719578403501,0.974918347544294
648,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.769357899670933,0.974918347544294
649,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.772579475001558,0.974918347544294
650,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.774060121711982,0.974918347544294
651,WP_IL7_SIGNALING,22,Down,0.774417236145352,0.974918347544294
652,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,12,Down,0.775282748832738,0.974918347544294
653,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Down,0.776666079859663,0.974918347544294
654,WP_ALLOGRAFT_REJECTION,50,Down,0.778866681754865,0.974918347544294
655,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,83,Up,0.780063044504422,0.974918347544294
656,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,111,Down,0.782051722890469,0.974918347544294
657,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.782184295074335,0.974918347544294
658,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.783259323308366,0.974918347544294
659,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,52,Down,0.784362632388403,0.974918347544294
660,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,18,Up,0.784513107437795,0.974918347544294
661,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.786479049262096,0.974918347544294
662,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.787543797100202,0.974918347544294
663,WP_IL3_SIGNALING,46,Up,0.78877245102286,0.974918347544294
664,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Up,0.788971808895277,0.974918347544294
665,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.789738670715727,0.974918347544294
666,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.792138324004181,0.974918347544294
667,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,2,Down,0.793116415155638,0.974918347544294
668,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Up,0.794081623444876,0.974918347544294
669,WP_PRIMARY_OVARIAN_INSUFFICIENCY,86,Down,0.796897644691593,0.974918347544294
670,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.799134355041436,0.974918347544294
671,WP_FOXA2_PATHWAY,9,Down,0.799375226574513,0.974918347544294
672,WP_NUCLEOTIDE_GPCRS,6,Up,0.801100750929101,0.974918347544294
673,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.801195411260103,0.974918347544294
674,WP_OMEGA9_FATTY_ACID_SYNTHESIS,9,Up,0.803190789336027,0.974918347544294
675,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.80457683367534,0.974918347544294
676,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Up,0.805214902830677,0.974918347544294
677,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.810013221143495,0.974918347544294
678,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,19,Up,0.811918446284421,0.974918347544294
679,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,122,Down,0.812125489754466,0.974918347544294
680,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,59,Down,0.813731392319424,0.974918347544294
681,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.813839853435176,0.974918347544294
682,WP_GASTRIC_CANCER_NETWORK_1,15,Down,0.814107219795212,0.974918347544294
683,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.814325903766203,0.974918347544294
684,WP_TCELL_RECEPTOR_SIGNALING,71,Down,0.816331248714756,0.974918347544294
685,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,14,Down,0.817075603766816,0.974918347544294
686,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.817274774059623,0.974918347544294
687,WP_ACE_INHIBITOR_PATHWAY,4,Up,0.820085851965997,0.974918347544294
688,WP_ACUTE_VIRAL_MYOCARDITIS,63,Down,0.820129184592287,0.974918347544294
689,WP_SPHINGOLIPID_PATHWAY,19,Down,0.82164831743467,0.974918347544294
690,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Down,0.821671930397762,0.974918347544294
691,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Up,0.822160978661283,0.974918347544294
692,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Down,0.82229146520957,0.974918347544294
693,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.822438905281535,0.974918347544294
694,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,24,Up,0.823767268677227,0.974918347544294
695,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,87,Up,0.825325266654335,0.974918347544294
696,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Up,0.825478308869621,0.974918347544294
697,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.828285297095588,0.975667211761451
698,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.829445521593406,0.975667211761451
699,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Up,0.830790817694056,0.975667211761451
700,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.833105061735599,0.975667211761451
701,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.83515638974462,0.975667211761451
702,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.836365921987037,0.975667211761451
703,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Up,0.836556296415227,0.975667211761451
704,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.836794871401245,0.975667211761451
705,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.836794871401245,0.975667211761451
706,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.843191152777904,0.977192023931082
707,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.843991951258958,0.977192023931082
708,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.844176848724728,0.977192023931082
709,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.846650933033902,0.977192023931082
710,WP_PROTEOGLYCAN_BIOSYNTHESIS,14,Up,0.847174119607874,0.977192023931082
711,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.848674694229456,0.977192023931082
712,WP_BDNFTRKB_SIGNALING,26,Down,0.848868604204959,0.977192023931082
713,WP_IL6_SIGNALING,39,Up,0.849222245140176,0.977192023931082
714,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,10,Down,0.850508760393621,0.977192023931082
715,WP_GPCRS_CLASS_A_RHODOPSINLIKE,38,Down,0.853822970924578,0.977192023931082
716,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Up,0.854185396129883,0.977192023931082
717,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,36,Up,0.854563845904428,0.977192023931082
718,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,13,Down,0.856247183843492,0.977192023931082
719,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Down,0.856467921296586,0.977192023931082
720,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,29,Down,0.856582844621562,0.977192023931082
721,WP_UREA_CYCLE_AND_RELATED_DISEASES,2,Up,0.857123417584319,0.977192023931082
722,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,27,Up,0.859637946119356,0.978505937319471
723,WP_IL11_SIGNALING,40,Up,0.863250875855943,0.978505937319471
724,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Up,0.863994437736292,0.978505937319471
725,WP_IL2_SIGNALING,36,Up,0.864107568016117,0.978505937319471
726,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.865700009978868,0.978505937319471
727,WP_CELLULAR_PROTEOSTASIS,6,Down,0.8658196714745,0.978505937319471
728,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,3,Up,0.866608664681964,0.978505937319471
729,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.870455212229694,0.979420259003548
730,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.871058259291105,0.979420259003548
731,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,13,Down,0.871987859539674,0.979420259003548
732,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,58,Down,0.873216304157267,0.979420259003548
733,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,10,Up,0.875537143342219,0.979420259003548
734,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,12,Down,0.876247608610376,0.979420259003548
735,WP_PYRIMIDINE_METABOLISM,71,Up,0.876631689609565,0.979420259003548
736,WP_GLIOBLASTOMA_SIGNALING,64,Up,0.877143192657038,0.979420259003548
737,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.880161760342901,0.979420259003548
738,WP_APOPTOSIS,70,Down,0.88368234499918,0.979420259003548
739,WP_MALE_INFERTILITY,66,Down,0.883687697782282,0.979420259003548
740,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.884026327954408,0.979420259003548
741,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.884788492079035,0.979420259003548
742,WP_OVARIAN_INFERTILITY,21,Up,0.888513705433432,0.979420259003548
743,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Down,0.889007855810735,0.979420259003548
744,WP_GLYCOLYSIS_IN_SENESCENCE,10,Up,0.889139324385254,0.979420259003548
745,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Down,0.890031498295762,0.979420259003548
746,WP_HEART_DEVELOPMENT,15,Up,0.890043188256931,0.979420259003548
747,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Up,0.890057096685706,0.979420259003548
748,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.89272353433927,0.979915136533502
749,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.896832028446765,0.979915136533502
750,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.896832028446765,0.979915136533502
751,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.897913942048234,0.979915136533502
752,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.899086121353865,0.979915136533502
753,WP_NETRINUNC5B_SIGNALING,35,Up,0.900437252787231,0.979915136533502
754,WP_GLUCURONIDATION,7,Down,0.901663751918261,0.979915136533502
755,WP_ECTODERM_DIFFERENTIATION,74,Down,0.905187139879671,0.979915136533502
756,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.905644077076107,0.979915136533502
757,WP_15Q25_COPY_NUMBER_VARIATION,28,Down,0.905800309543358,0.979915136533502
758,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.90676983394668,0.979915136533502
759,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.906887969605924,0.979915136533502
760,WP_PARKINSONS_DISEASE_PATHWAY,26,Up,0.907999948969868,0.979915136533502
761,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.909429714643233,0.979915136533502
762,WP_PPARALPHA_PATHWAY,14,Down,0.909810305443332,0.979915136533502
763,WP_ENDODERM_DIFFERENTIATION,80,Up,0.909994797845559,0.979915136533502
764,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Down,0.910772705975177,0.979915136533502
765,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Up,0.912701282609427,0.980118935216862
766,WP_MAPK_CASCADE,30,Up,0.913627788600029,0.980118935216862
767,WP_PI3KAKT_SIGNALING,171,Up,0.914539201108678,0.980118935216862
768,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,64,Down,0.920663662905867,0.984285137899805
769,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.921611390272252,0.984285137899805
770,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.924665174131839,0.984285137899805
771,WP_OXIDATION_BY_CYTOCHROME_P450,14,Down,0.926658658340584,0.984285137899805
772,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.929153318852981,0.984285137899805
773,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.929163322250161,0.984285137899805
774,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.929800924183295,0.984285137899805
775,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.930003096950759,0.984285137899805
776,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.930241296456834,0.984285137899805
777,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.930400915022079,0.984285137899805
778,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Down,0.932169093206563,0.984348316433137
779,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,59,Up,0.932871041617263,0.984348316433137
780,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,163,Up,0.934053146980349,0.984348316433137
781,WP_TCELL_ACTIVATION_SARSCOV2,61,Up,0.937506470942621,0.985721877121764
782,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.93775487580197,0.985721877121764
783,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Up,0.939897733727945,0.98611458792622
784,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Up,0.941032620156822,0.98611458792622
785,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.942974044407881,0.98611458792622
786,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.944717051705177,0.98611458792622
787,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.945232494346631,0.98611458792622
788,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,14,Up,0.945326393291803,0.98611458792622
789,WP_VITAMIN_D_METABOLISM,5,Up,0.951247671595169,0.988140019345726
790,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Up,0.951538736188839,0.988140019345726
791,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.952190008958459,0.988140019345726
792,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.955676434332599,0.988140019345726
793,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,11,Down,0.955704824955847,0.988140019345726
794,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.956548501298365,0.988140019345726
795,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,267,Down,0.957125794974522,0.988140019345726
796,WP_CAMKK2_PATHWAY,29,Down,0.958272608252712,0.988140019345726
797,WP_INSULIN_SIGNALING,125,Up,0.959062454035181,0.988140019345726
798,WP_BURN_WOUND_HEALING,57,Up,0.959289215861179,0.988140019345726
799,WP_LEPTIN_SIGNALING,69,Up,0.966099386614305,0.990542512068198
800,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,27,Down,0.966380389964291,0.990542512068198
801,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,9,Up,0.967534112263068,0.990542512068198
802,WP_ATR_SIGNALING,10,Down,0.967812292191595,0.990542512068198
803,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.968563151422032,0.990542512068198
804,WP_ANGIOGENESIS,13,Down,0.968851800125099,0.990542512068198
805,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Up,0.971166103167086,0.991675200997944
806,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.974181369838976,0.991793033723387
807,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,27,Down,0.975904124067936,0.991793033723387
808,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Up,0.97599161291209,0.991793033723387
809,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.976107742435791,0.991793033723387
810,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,11,Up,0.979986643011306,0.994504963648511
811,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.981219298016496,0.994528067779974
812,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.982923159669636,0.995028124690198
813,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.984516889391615,0.995339525658394
814,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.985652522975587,0.995339525658394
815,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Up,0.987143129745413,0.995621659694147
816,WP_CILIOPATHIES,120,Up,0.990752631256835,0.997426833200191
817,WP_ADIPOGENESIS,82,Down,0.992687894915649,0.997426833200191
818,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.993403212964742,0.997426833200191
819,WP_GLYOXYLATE_METABOLISM,5,Up,0.994474708068703,0.997426833200191
820,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Up,0.995000003922331,0.997426833200191
821,WP_ASPIRIN_AND_MIRNAS,8,Down,0.997537839118821,0.997577737818949
822,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.997577737818949,0.997577737818949
